DFX Intelligence
Borrowers
38 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Industry as filed contains “Life Sciences Tools & Services” (remove)
Start from
38 borrower groups
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Creek Parent, Inc Life sciences | unattributed | 24 | at least $1.8B | 100c | 3 pts | Dec 1, 2031 | Sep 30, 2024 |
| Packaging Coordinators Midco, Inc Life sciences | unattributed | 26 | at least $1.7B | 100c | 4 pts | Jul 1, 2027 | Dec 31, 2021 |
| Cambrex Corp Life sciences | unattributed | 15 | at least $895M | 100c | 1 pts | Mar 1, 2032 | Dec 31, 2021 |
| K••• A••••••••• I•• Life sciences | K••••••• • C•••••• inferred | 13 | at least $763M | 100c | 3 pts | Dec 1, 2029 | Dec 31, 2022 |
| S•••••• F•••••• O•• L•••••• Life sciences | unattributed | 11 | at least $640M | 100c | 2 pts | Oct 1, 2031 | Dec 31, 2025 |
| E••••• B•••• A• Life sciences · grade B | unattributed | 2 | at least $432M | 97c | 0 pts | Sep 22, 2032 | Sep 30, 2024 |
| C•••• G•••••• I•• Life sciences | unattributed | 8 | at least $326M | 60c | 72 pts | Dec 6, 2029 | Dec 31, 2021 |
| M•••• N• I•• Life sciences | unattributed | 16 | at least $262M | 100c | 1 pts | May 13, 2031 | Jun 30, 2024 |
| P•••••• I••••••••• I•• Life sciences | unattributed | 16 | at least $163M | 100c | 1 pts | Dec 1, 2031 | Dec 31, 2022 |
| B•••••• I••••••••• H•••••• C••• Life sciences | unattributed | 13 | at least $156M | 101c | 1 pts | Oct 1, 2031 | Dec 31, 2021 |
| R•• S•••••••• I•• Life sciences | unattributed | 7 | at least $71.7M | 100c | 0 pts | Sep 1, 2032 | Dec 31, 2021 |
| R••• C••• Life sciences | unattributed | 3 | at least $48.8M | 73c | 1 pts | Aug 31, 2029 | Dec 31, 2022 |
| W•••••• P••••••••• L•• Life sciences | unattributed | 7 | at least $37.1M | 101c | n/a | Nov 6, 2030 | Dec 31, 2023 |
| W•••• H••••• C••••••••• L•• Life sciences | Sponsor not establishedpossible: R•••••• A••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $30.1M | 101c | n/a | Oct 23, 2028 | Dec 31, 2025 |
| K• M••• A••••••••• L•• Life sciences | unattributed | 3 | at least $29.6M | 99c | n/a | Feb 1, 2029 | Mar 31, 2023 |
| T••••• M•••••• C•••••••• I•• Life sciences | unattributed | 5 | at least $25.1M | 100c | n/a | Jan 31, 2031 | Dec 31, 2022 |
| D•••••••• I•• Life sciences | unattributed | 4 | at least $15.4M | 100c | 0 pts | Dec 18, 2029 | Dec 31, 2022 |
| A••••• B•• A••••• B••••••••• L•• Life sciences | unattributed | 1 | at least $15.3M | 96c | n/a | Jun 1, 2029 | Jun 30, 2024 |
| E••• I••••••••• I• L•• Life sciences | unattributed | 2 | at least $14.7M | 101c | n/a | Sep 26, 2031 | Sep 30, 2025 |
| S••••• H••••• H•••••••• L•• Life sciences | unattributed | 6 | at least $13.0M | 100c | 0 pts | May 30, 2031 | Mar 31, 2023 |
| T•••• L•••• I• S••• Life sciences | unattributed | 4 | at least $12.8M | 101c | 0 pts | Jun 12, 2031 | Jun 30, 2025 |
| Q••• U• M•••• 2• L•••••• F••••••• B• Life sciences | unattributed | 1 | at least $12.7M | 100c | n/a | Jun 30, 2029 | Jun 30, 2026 |
| Q••••••• S•••••• Life sciences | unattributed | 1 | at least $12.7M | 100c | n/a | Sep 12, 2026 | Dec 31, 2025 |
| T•• A••••••••• Life sciences | S••••••••• L•• inferred | 1 | at least $8.9M | 101c | n/a | Mar 12, 2031 | Jun 30, 2025 |
| U•••••••• L•••• L•• Life sciences | unattributed | 4 | at least $6.7M | 100c | n/a | Aug 1, 2029 | Sep 30, 2021 |
| K• C•••••• A••••••••• C•••••• F••••• A•••••••• Life sciences | unattributed | 1 | at least $4.7M | 101c | n/a | Dec 30, 2026 | Mar 31, 2024 |
| C•••• R••••••••• I• S•• L•• Life sciences | unattributed | 3 | at least $4.5M | 100c | n/a | Jan 29, 2029 | Dec 31, 2025 |
| B••••• U• B•••• L•• U•• Life sciences | unattributed | 1 | at least $696,000 | 100c | n/a | Sep 30, 2030 | Sep 30, 2025 |
| T••••••• Life sciences | unattributed | 2 | at least $689,655 | 113c | n/a | Jun 23, 2032 | Dec 31, 2025 |
| K• C•••••• A••••••••• C•••••• S•••• A•••••••• Life sciences | unattributed | 1 | at least $383,000 | 100c | n/a | Dec 30, 2026 | Dec 31, 2024 |
| E•••• B••••••• I•• Life sciences | unattributed | 2 | at least $254,000 | 99c | n/a | Jul 7, 2028 | Mar 31, 2022 |
| B••••• U• B•••• L•• T•••••• B•• D•••••• Life sciences | unattributed | 1 | at least $167,000 | 101c | n/a | Sep 30, 2030 | Dec 31, 2024 |
| B••••• U• B•••• L•• D•••••• Life sciences | unattributed | 1 | at least $106,000 | 101c | n/a | Sep 30, 2030 | Dec 31, 2024 |
| K• C•••••• A••••••••• C•••••• S•••••• A•••••••• Life sciences | unattributed | 1 | at least $56,000 | n/a | n/a | Dec 30, 2026 | Jun 30, 2025 |
| A••••• C••••••••• S• S•••••• Life sciences | unattributed | 2 | at least $0 | n/a | n/a | Dec 21, 2029 | Dec 31, 2022 |
| K• C•••••• A••••••••• C•••••• E•••• A•••••••• Life sciences | unattributed | 1 | at least $0 | n/a | n/a | Dec 30, 2029 | Mar 31, 2026 |
| A••••• T••••••••• L•• Life sciences | unattributed | 1 | unknown | 100c | n/a | Dec 21, 2027 | Sep 30, 2025 |
| G•••• E••• B•••••• L•• Life sciences | unattributed | 2 | unknown | n/a | n/a | unstated | Sep 30, 2025 |
Page 1 of 1
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.